Regaining lost youth: the controversial and colorful beginnings of hormone replacement therapy in aging
- PMID: 15814854
- DOI: 10.1093/gerona/60.2.142
Regaining lost youth: the controversial and colorful beginnings of hormone replacement therapy in aging
Abstract
The quest for regaining lost youth seems to have existed since the beginning of recorded history and has taken many forms. One strategy that began in earnest in the latter part of the 19th century and continues to have enormous momentum today is based on the notion that by replacing internally secreted substances, that is, hormones, that decline with age, the vitality and physical attributes associated with youth can be regained. Although the approach remains highly controversial as, for example, in "anti-aging medicine," it is no more controversial than it was many years ago when the work of three high profile investigators, Charles Eduoard Brown-Séquard, Eugen Steinach, and Serge Voronoff set the basis for using this strategy. In the case of all three individuals, the therapies they developed received widespread attention (including ridicule) in the popular press, were spread rapidly by practitioners of questionable training and ethical motivation, and finally and relatively quickly disappeared from common use. However, and ultimately more importantly, in the process of developing and promoting their therapies, these individuals made important contributions to the origins of endocrinology, the biology of sex, and establishment of hormone replacement therapy. It remains to be seen whether contemporary efforts using hormone replacement therapy to blunt and reverse aging have the same fate as their predecessors and make comparable important contributions to biology and medicine.
Similar articles
-
[Doctor Brown-Sequard's therapy].Ann Endocrinol (Paris). 2010 Mar;71(2):69-75. doi: 10.1016/j.ando.2010.01.003. Epub 2010 Feb 18. Ann Endocrinol (Paris). 2010. PMID: 20167305 French.
-
Injection, ligation and transplantation: the search for the glandular fountain of youth.J Urol. 2007 Jun;177(6):2000-5. doi: 10.1016/j.juro.2007.01.135. J Urol. 2007. PMID: 17509279
-
A brief history of rejuvenation operations.J Urol. 2012 Mar;187(3):1130-4. doi: 10.1016/j.juro.2011.10.134. Epub 2012 Jan 21. J Urol. 2012. PMID: 22266009
-
The emergence of levothyroxine as a treatment for hypothyroidism.Endocrine. 2017 Jan;55(1):6-18. doi: 10.1007/s12020-016-1199-8. Epub 2016 Dec 16. Endocrine. 2017. PMID: 27981511 Review.
-
Replacement therapy in the aging male.J Endocrinol Invest. 2002;25(10 Suppl):2-9. J Endocrinol Invest. 2002. PMID: 12508905 Review.
Cited by
-
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Endocr Rev. 2014 Jun;35(3):341-75. doi: 10.1210/er.2013-1058. Epub 2013 Dec 17. Endocr Rev. 2014. PMID: 24423981 Free PMC article. Review.
-
Nucleic acid therapy for lifespan prolongation: present and future.J Biosci. 2011 Sep;36(4):725-9. doi: 10.1007/s12038-011-9096-z. J Biosci. 2011. PMID: 21857119 Review.
-
An old emperor finds new clothing: rejuvenation in our time.Asian J Androl. 2011 Jan;13(1):125-9. doi: 10.1038/aja.2010.154. Epub 2010 Nov 22. Asian J Androl. 2011. PMID: 21102475 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical